Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase

被引:6
作者
Lee, TC [1 ]
Malone, B
Longobardi, L
Balestrieri, ML
机构
[1] Oak Ridge Associated Univ, Basic & Appl Res Unit, Oak Ridge, TN 37831 USA
[2] Univ Naples 2, Dept Biochem & Biophys F Cedrangolo, I-80138 Naples, Italy
关键词
platelet-activating factor; transacetylase; acetylhydrolase; C-2-ceramide; analogs of PAF;
D O I
10.1006/abbi.2000.2226
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously established that PAF-dependent transacetylase (TA) purified to apparent homogeneity from rat kidney membranes and cytosol contains three separate catalytic activities, namely PAF lysophospholipid transacetylase (TA(1)), PAF sphingosine transacetylase (TA(s)), and PAF acetylhydrolase (AH), In the present investigation, we studied the biochemical factors and mechanism(s) that differentially regulate these three TA activities of the purified enzymes. We found that only the TA(s) activity of the TA purified from the membranes was stimulated by phosphatidylserine (PS) with optimal concentration of activation occurring at 25 muM, Other acidic phospholipids, such as phosphatidylinositol (PI) and phosphatidylinositol I-phosphate (PIP), are partially effective, while diacylglycerol and free fatty acids had no effect on the TA(s) activity. PS exerted its effect on the TA(s) activity through the increases of both K-m and V-max. In addition, N-ethylmalimide (NEM) and dithiobis-(2-nitro-5-thiobenzoic acid) (DTNB) strongly inhibited the TA(L) activity and partially decreased the TA(L) and AH activities of the purified membrane enzyme in a dose-dependent manner. The addition of PS, but not by its substrate, sphingosine, could prevented the inhibition by NEM on the basal level of TA(s). On the other hand, the inhibition of TAL by NEM and DTNB were partially protected by the substrate, lysoplasmalogens, Furthermore, PAF fully protects the inhibition of AH, partially protects the inhibition of TA(L), and does not protect the inhibition of TA(s) by NEM, These results suggested that the three individual catalytic activities of TA have different dependencies on the thiol-containing residue(s) of the enzyme, i.e., cysteine. Furthermore, the nonresponsiveness of the purified cytosolic TA(s) to PS activation is consistent with our previous notions that membrane and cytosolic TA are posttranslationally distinct. (C) 2001 Academic Press.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
[21]   Potential Therapeutic Strategies for Severe Anaphylaxis Targeting Platelet-Activating Factor and PAF Acetylhydrolase [J].
Upton J. ;
Vadas P. .
Current Treatment Options in Allergy, 2014, 1 (3) :232-246
[22]   Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor [J].
Vladislava Melnikova ;
Menashe Bar-Eli .
Cancer and Metastasis Reviews, 2007, 26 :359-371
[23]   Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor [J].
Melnikova, Vladislava ;
Bar-Eli, Menashe .
CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) :359-371
[24]   Platelet-Activating Factor (PAF): A Review of its Role in Asthma and Clinical Efficacy of PAF Antagonists in the Disease Therapy [J].
Kasperska-Zajac, Alicja ;
Brzoza, Zenon ;
Rogala, Barbara .
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2008, 2 (01) :72-76
[25]   Platelet-activating factor acetylhydrolases in health and disease [J].
Tjoelker, LW ;
Stafforini, DM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1488 (1-2) :102-123
[26]   The structure and function of platelet-activating factor acetylhydrolases [J].
Derewenda, ZS ;
Derewenda, U .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (05) :446-455
[27]   Platelet-Activating Factor Disrupts the Nasal Epithelial Barrier Independently of the Platelet-Activating Factor Receptor Pathway [J].
Tan, Juan ;
Han, Xinling ;
Li, Shenting ;
Wang, Qiqi ;
Zhao, Limin ;
Li, Ying ;
Duan, Su ;
Zhang, Luo .
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2025, 17 (02) :212-225
[28]   Protein tyrosine phosphorylation in equine platelets: The effect of stimulation by thrombin and platelet-activating factor (PAF) [J].
Dillon, AMR ;
Heath, MF .
EQUINE VETERINARY JOURNAL, 1995, 27 (06) :448-458
[29]   Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases [J].
Baker, PRS ;
Owen, JS ;
Nixon, AB ;
Thomas, LN ;
Wooten, R ;
Daniel, LW ;
O'Flaherty, JT ;
Wykle, RL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1592 (02) :175-184
[30]   Platelet-activating factor and human meningiomas [J].
Denizot, Y. ;
De Armas, R. ;
Caire, F. ;
Pommepuy, I. ;
Truffinet, V. ;
Labrousse, F. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (06) :674-678